-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)
-
-
-
-
-
-
-
Cantor Biotech industry report, buying value in RevGens
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Raised to $124 at Cantor Fitzgerald
-
-
-
-
-
-
-
Cantor Fitzgerald Starts Solid Biosciences (SLDB) at Overweight
-
-
-
-
-
-
-
Marinus Pharmaceuticals (MRNS) PT Raised to $28 at Cantor Fitzgerald
-
-
-
-
-
-
-
UPDATE: Cantor Fitzgerald Starts vTv Therapeutics (VTVT) at Overweight; Sees 800% Upside
-
-
-
-
-
-
-
UPDATE: Cantor Fitzgerald Starts Lucid Diagnostics Inc (LUCD) at Overweight
-
416 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

